Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Corvus Pharmaceuticals, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
OA
Orbimed Advisors LLC
13D · 10.3%
|
7.2M | 7.75% | Unchanged | ≤2021 | 2.0% | |
|
Shares held by quarter
Peak holding7.2M (Q2'25)
Change over 8 quarters+221.4K
Share of the company7.750%
Disclosed stake13D · 10.3%
|
||||||
|
B
BlackRock, Inc.
|
7.1M | 7.72% | +978.4K (+15.9%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding7.1M (Q2'26)
Change over 8 quarters+6.5M
Share of the company7.720%
|
||||||
28 more super investors behind a free account
See every manager holding Corvus Pharmaceuticals, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
SS
SPDR Series Trust
|
$43.8M | 2.9M | 3.17% | 0.41% | June 30, 2026 |
|
VT
Vanguard Index Funds
|
$35.5M | 2.4M | 2.57% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Corvus Pharmaceuticals, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
TP
Thompson Peter A.
Insider
|
8.8M | 9.54% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company9.540%
|
||||||
|
OC
Orbimed Capital GP V LLC
5%+ holder
13D · 10.3%
|
8.6M | 9.31% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
14 more holders behind a free account
See every insider and 5%+ holder of Corvus Pharmaceuticals, Inc..
Sign up freeLoading...